Start with its own history
At 110.49×, LFTSF is 211.2% above its 5-observation annual average. A lower multiple can reflect a lower price, higher earnings, or weaker growth expectations—not necessarily a bargain.
OTC · LFTSFMedical - DevicesUpdated Nov 5, 2026
LifeTech Scientific Corporation P/E ratio
Current valuation, historical context, and peer comparisons.
Current P/E ratio
110.49×
211.2% abovethe 5-observation annual average
Share price0.2
÷Earnings per share0.0018
Price and EPS in quote currency. Calculation details
Investors are paying 110.49 for every 1 of reported earnings per share.
P/E over time
2021 – 2025
Annual P/ESelected-period average 35.51×
3-year average34.71×3 positive annual observations
5-year average35.51×5 positive annual observations
10-year average35.51×5 positive annual observations
Peer median · TTM19.23×4 peers with positive P/E
Historical P/E ratios
Annual period-end data · 5 observations
| Period end | P/E | Change |
|---|---|---|
| Dec 31, 2025 | 42.46× | +65.2% |
| Dec 31, 2024 | 25.70× | -28.6% |
| Dec 31, 2023 | 35.97× | +21.6% |
| Dec 31, 2022 | 29.59× | -32.5% |
| Dec 31, 2021 | 43.83× | N/M |
Change is relative to the preceding observation. N/M values are excluded from averages.
How LFTSF compares
Company P/E vs. peer trailing-12-month ratios
| Company | P/E ratio |
|---|---|
 LFTSF This stockLifeTech Scientific Corporation | 110.49× |
 2291.HKLEPU ScienTech Medical Technology (Shanghai) Co., Ltd. | 20.96× |
 2190.HKZylox-Tonbridge Medical Technology Co., Ltd. | 17.49× |
 6609.HKShanghai HeartCare Medical Technology Corporation Limited | 16.35× |
 1501.HKShanghai Kindly Medical Instruments Co., Ltd. | 21.45× |
 2500.HKVenus Medtech (Hangzhou) Inc. | N/M |
 9877.HKJenscare Scientific Co., Ltd. | N/M |
 2185.HKShanghai Bio-heart Biological Technology Co., Ltd. | N/M |
 6669.HKAcotec Scientific Holdings Limited | N/M |
Peers are selected by the data provider. Business models and earnings definitions can differ.
Put the numbers in context
What does LFTSF’s P/E tell you?
Compare like with like
The median of the 4 positive peer ratios above is 19.23×. Check growth, margins, debt, and earnings quality before interpreting the gap. A faster-growing business may justify a higher multiple.
Check what drives earnings
One-off gains can temporarily lower P/E; unusual charges can raise it. Reported earnings and forward estimates answer different questions. Pair this view with return on equity and liquidity for a fuller picture.
Keep your research connected
Take LFTSF into your spreadsheet
Pull historical P/E into Excel or Google Sheets with Wisesheets. Build your own comparisons alongside the rest of your financial model.
Explore WisesheetsQuarterly P/E · latest quarterLQ selects the latest reported quarter. Requires the Wisesheets add-in. See available data
=WISE("LFTSF", "PE Ratio", "LQ")Sources & calculation methodology
Current P/E
Share price 0.2 ÷ EPS 0.0018 = 110.49×. Data is supplied by Financial Modeling Prep through Wisesheets. Quote feed updated Nov 5, 2026; this is not a real-time trading quote.
History & averages
Annual and quarterly P/E observations are provided separately from the current quote. Averages use the latest 3, 5, or 10 annual observations, excluding missing and nonpositive ratios. Pre-IPO observations are omitted. These are period-end observations, not daily averages.
Data definitions and limitations
The current quote feed does not specify the exact EPS filing-period end or whether EPS is basic or diluted. We do not label it as forward P/E. Peer ratios are explicitly trailing-12-month (TTM) values. Historical observations do not include independently verified price and EPS inputs. Sources may update on different schedules; rounded inputs can produce small calculation differences. Historical comparisons describe past pricing, not an estimate of fair value.
LFTSF P/E ratio: common questions
The essentials behind the numbers.
LifeTech Scientific Corporation's current P/E is 110.49× based on the quote data last updated Nov 5, 2026. It represents the share price divided by reported earnings per share. Prices and earnings may refresh on different schedules.
Annual P/E uses earnings for a completed fiscal year. Trailing-12-month (TTM) P/E uses the latest four quarters, while forward P/E uses forecast earnings. These are not interchangeable. This page labels peer ratios as TTM and shows dated annual or quarterly historical observations; it does not show forward estimates.
N/M means not meaningful: the feed has no positive P/E for that observation. Negative or zero earnings should not be ranked as a low positive valuation multiple. N/M observations are excluded from the averages shown above.
Divide the share price by earnings per share (EPS). For example, a share price of 100 and EPS of 5 gives a P/E of 20×. This page uses the price and EPS supplied together in the quote when both are positive.
Price timestamps, EPS definitions, share classes, adjustments, and fiscal periods can differ. A forward P/E also uses forecast earnings rather than reported earnings. Compare the inputs and as-of dates before comparing two displayed ratios.
Not necessarily. The average describes previous market pricing, not fair value. Changes in earnings quality, growth expectations, debt, accounting, and business risk can justify a different multiple today.